China approves Pfizer GLP-1 drug for weight loss

By Andrew Silver SHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight ...
AASTOCKS.com

Pfizer's Weight Loss Injection GLP-1 Ecnoglutide Injection Approved in CN

He Xiaopeng: XPENG-W to Skip L3-lv. Autonomous Driving, Directly Deploy L4 Mass Production; Annual R&D Investment Expected to ...

China Clears Weight-Loss Shot As Pfizer Enters Crowded Market

China's National Medical Products Administration has approved Pfizer Inc.’s PFE ecnoglutide injection for chronic weight management in adults with overweight or obesity, marking the first approval of ...

Sciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China

Hangzhou Sciwind Biosciences Co., Ltd. ("Sciwind Biosciences") today announced a strategic commercialization collaboration with Pfizer China for Ecnoglutide injection (Ecnoglutide), a new–generation ...

Pfizer in diabetes drug deal with Sciwind Biosciences

SHANGHAI, Feb 24 () - Pfizer has entered an agreement to license Sciwind Biosciences' type 2 diabetes treatment ‌ecnoglutide, ...

Pfizer Adds Sciwind As China Partner For New Weight Loss Drug

Agreement worth up to $495 million is part of a growing number of Chinese deals with global pharma giants as the country ...

China approves Pfizer GLP-1 drug for weight management

SHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the US drugmaker said on WeChat on Friday, boosting ...